
AML.L vs RIVN

In the past 12 months, RIVN returned -4% while AML.L lost 42%.
Valuation
Compare price multiples and valuation ratios
| Metric | AML.L | RIVN | Winner |
|---|---|---|---|
P/E Ratio Price to earnings ratio | -0.60 | -4.81 | RIVN |
Forward P/E Forward price to earnings ratio | 0.00 | 0.00 | Tie |
P/S Ratio Price to sales ratio | 0.22 | 3.05 | AML.L |
P/B Ratio Price to book ratio | 2.11 | 3.12 | AML.L |
P/FCF Ratio Price to free cash flow ratio | -1.49 | -5.14 | RIVN |
EV/EBITDA Enterprise value to EBITDA | 7.44 | -9.21 | RIVN |
PEG Ratio Price/earnings to growth ratio | 0.00 | 0.00 | Tie |
Profitability
Compare profit margins and returns on capital
| Metric | AML.L | RIVN | Winner |
|---|---|---|---|
Gross Margin Gross profit margin | 18.5% | 7.5% | AML.L |
Operating Margin Operating profit margin | -13.3% | -60.1% | AML.L |
Net Margin Net profit margin | -36.7% | -55.0% | AML.L |
ROE Return on equity | -166.6% | -67.5% | RIVN |
ROA Return on assets | -23.7% | -21.4% | RIVN |
ROIC Return on invested capital | -11.5% | -30.4% | AML.L |
Growth
Compare revenue and earnings growth rates
| Metric | AML.L | RIVN | Winner |
|---|---|---|---|
Revenue Growth (YoY) Year-over-year revenue growth | -20.6% | 8.4% | RIVN |
Revenue Growth (3Y) 3-year revenue CAGR | -3.1% | 48.1% | RIVN |
Revenue Growth (5Y) 5-year revenue CAGR | 15.5% | 0.0% | AML.L |
EPS Growth (YoY) Year-over-year EPS growth | -28.2% | 34.5% | RIVN |
EPS Growth (3Y) 3-year EPS CAGR | 0.0% | 0.0% | Tie |
EPS Growth (5Y) 5-year EPS CAGR | 0.0% | 0.0% | Tie |
Balance Sheet & Risk
Compare financial stability and debt levels
| Metric | AML.L | RIVN | Winner |
|---|---|---|---|
Debt/Equity Debt to equity ratio | 8.94 | 1.04 | RIVN |
Current Ratio Current assets to current liabilities | 0.93 | 2.10 | RIVN |
Quick Ratio Quick assets to current liabilities | 0.49 | 1.65 | RIVN |
Interest Coverage EBIT to interest expense | -1.43 | -13.28 | AML.L |
Beta Stock volatility vs market | 1.94 | 1.62 | RIVN |
7222.T
PSNY
LOT